Impact of CD38 knockout in NK cells on daratumumab-mediated cytotoxicity and cellular metabolism.

e15018Background: Multiple myeloma (MM) is a neoplasm of plasma cells. These cells express high levels of CD38 and are sensitive to daratumumab (DARA), a CD38-targeting monoclonal antibody. DARA ki...